Lexpos News

/Lexpos News

We’re coming to a town near you

Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the first week of June. The series of interactive evening sessions will bring local pharmacies together with the people negotiating on their behalf to talk openly about funding, the challenges facing [...]

The post We’re coming to a town near you appeared first on Community Pharmacy England.

By |May 11th, 2026|Lexpos News|Comments Off on We’re coming to a town near you

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...]

The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.

By |May 11th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd)

IT system selection survey

NHS IT teams want to learn how community pharmacy owners and decision makers decide which services IT system to use or move towards when system decisions are being made. The aim would be to help pharmacy owners choose pharmacy IT systems and services (e.g. a Pharmacy First IT solution) more easily, in a clearer and [...]

The post IT system selection survey appeared first on Community Pharmacy England.

By |May 11th, 2026|Lexpos News|Comments Off on IT system selection survey

MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings

The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The product [...]

The post MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings appeared first on Community Pharmacy England.

By |May 11th, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings

Expressions of interest open for East and North Midlands Representative

Eligible pharmacists in the East and North Midlands have been invited to express interest in joining Community Pharmacy England’s Committee. Expressions of Interest are now being sought as part of the mid-term election process for an ‘Independent regional representative’ for Community Pharmacy England’s East and North Midlands region. Interested LPC members or officers in the [...]

The post Expressions of interest open for East and North Midlands Representative appeared first on Community Pharmacy England.

By |May 8th, 2026|Lexpos News|Comments Off on Expressions of interest open for East and North Midlands Representative